Navigation Links
Health care disparities seen in epilepsy patients with low socioeconomic status
Date:2/22/2011

A newly published report reveals patients with epilepsy and low socioeconomic status (SES) are more likely to have uncontrolled seizures, drug-related side effects, and a lower overall quality of life. The study also indicates that low SES patients used the hospital emergency room more often and had more visits to a general practitioner than epileptic patients at higher socioeconomic levels. Full findings are now available in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

The Centers for Disease Control and Prevention (CDC) estimates that two million Americans have epilepsy and roughly 140,000 new cases are diagnosed each year. Prior studies in epilepsy literature provide evidence of disparities in healthcare use between individuals of different SES. One study found that epileptic patients with incomes below the poverty level in California were 50% less likely than those with higher income (not in poverty) to report taking epilepsy medication (Elliott et al., 2009).

"Current medical evidence is based on point-in-time comparisons across population and suggests that disparities in healthcare may be due to access difficulties," explains lead study author Dr. Charles E. Begley, Professor of Management & Health Sciences at the University of Texas Health Science Center in Houston. "Our study investigates disparities in healthcare over time, examining the impact of SES in patients with epilepsy who have access to regular care."

Researchers enrolled 566 adult patients with epilepsy from three clinics in Houston and New York City serving a low-SES population, and one in Houston serving high-SES patients. Participants were interviewed at baseline regarding healthcare use, seizure frequency and type, anti-epileptic drug (AED) side effects, and outcomes during the prior three-month and one-year periods. The survey was repeated several times during the year-long study period.

Indicators of SESincome, education, employment, and insurance coveragewere significantly lower for patients at low-SES sites compared to the higher-SES site. Patients at the low-SES sites had consistently higher emergency room use and visits to the general practitioner. Throughout the one-year study period low-SES patients had significantly higher likelihoods of poor outcomes2.2 to 3.9 times more likely to have uncontrolled seizures and 4.9 to 16.3 times more likely to have AED side effectscompared with higher-SES patients.

The authors determined that significant disparities in patterns of care and outcomes of low and high-SES patients receiving regular care for epilepsy were persistent over the one-year study period. "Future research needs to examine specific site-related factors that may be associated with these disparities in care for individuals with epilepsy," concluded Dr. Begley.


'/>"/>

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. One Health: From ideas to implementation, rhetoric to reality
2. How we manage water resources has a direct impact on our health, says Canada Research Chair
3. 1 person of 1,900 met AHAs definition of ideal heart health, says University of Pittsburgh study
4. Innovative International Healthcare Partnership established at Arizona State University
5. IOM and NAE launch collegiate challenge aimed at solving health problems
6. Improved behavioral health needed to respond to rising number of suicides among US Armed Forces
7. Healthy lifestyle, positive attitude can help improve patient outcomes
8. Children of working moms face more health problems
9. Americas Health a Mixed Bag: Report
10. New Factor May Spot Heart Risks in Healthy People: Study
11. Most New Jersey residents see global health as critical to states economy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... Roxanna Cross will host ... the 11th Annual RISE Nashville Summit. RISE Nashville is the healthcare industry’s premier ... strategies. , The discussion will include best practices for accurate identification and capture ...
(Date:2/27/2017)... ... February 27, 2017 , ... Anahata ... Spiritual Awakening, is happy to announce her “Spring Rejuvenation in Sedona” personally ... individual customized retreats offer the winter-weary soul an excellent opportunity to come out ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... an overview on laser diffraction analysis as a tool to characterize particle size ... and potential to obtain improved results and novel scientific findings. It describes methods ...
(Date:2/27/2017)... San Francisco, CA (PRWEB) , ... February 27, ... ... Area center for hair transplantation therapy, is proud to announce a new informational ... popular hair therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is an ... world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house ... is the globally recognised standard that sets out requirements for the technical competence ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... OCEAN VIEW, Delaware , February 27, 2017 ... (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode ... Research Organizations, Healthcare Providers), Industry Analysis Report, Regional Outlook (U.S., ... , Poland , Russia , ... Japan , South Korea , Taiwan ...
(Date:2/27/2017)... , Feb. 27, 2017   Royal Philips ... a global leader in health technology, today announced ... Administration (FDA) to market its ElastQ Imaging capability, ... of ultrasound systems. ElastQ Imaging enables simultaneous imaging ... is essential for the diagnosis of various liver ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
Breaking Medicine Technology: